oncology patient-centered medical home ® business case for quality value based hematology and...
TRANSCRIPT
![Page 1: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/1.jpg)
Oncology Patient-Centered Medical Home®
Business Case for Quality
Value Based Hematology and Oncology Care
John D. Sprandio, M.D., FACP Consultants in Medical Oncology & Hematology, P.C.
Oncology Management Services, LLC.
Philadelphia, PA
![Page 2: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/2.jpg)
Agenda
• Rocket Science, Physician role, PCMH, Cancer• Performance Measurement• Oncology PCMH Model• Results• Replication• Stakeholder Perspective• Conclusion – it’s not just about Cancer
![Page 3: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/3.jpg)
Rocket SciencePhysician’s Central RolePrimary PCMHFocus on Cancer Care
![Page 4: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/4.jpg)
What’s Wrong with the US Health Care Delivery System?
Continuum of health care scienceBasic science – unravels mysteriesTranslational research – develop new treatmentsPolicy analysts – measure outcomesFundamental Question: How is care best delivered?
Dartmouth Center for Health Care Delivery Science
“The real rocket science now in health care is cost and quality.”
Dr. Jim Yong Kim
![Page 5: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/5.jpg)
US Health Care
Focus on Cost: 2012 health care costs $ 2.8 trillion
Taken alone = the worlds 5th largest economy
We outspend the rest of industrialized world90% on rescue, 10% on chronic care verses 50/50
Targeting waste due to failures in:Delivery PricingCoordination Administrative burdenOverutilization Fraud
Focus on Quality: Legislation, Regulation, Enforcement, Policy Development, Market Demands
![Page 6: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/6.jpg)
Doing Well by Doing Good:Improving the Business Case for Quality
Gosfiled, Reinertsen, et al. 2003
Physician engagement is essential in driving quality
Centrality of doctor-patient relationship:
• Most personal & critical interaction that defines healthcareExplanation, prediction, plan of care
• Physicians have a broadest scope of professional jurisdictionDrive the provision of all goods and services
• Patient experience based on one-on-one relationship• Physicians are the patient portal to the rest of the system
Referrals, education, interpretation of insurance benefits
![Page 7: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/7.jpg)
Doing Well by Doing Good:Improving the Business Case for Quality
Gosfiled, Reinertsen, et al. 2003
Barriers to quality = physician “time stealers”Incentives, EMR, work-flow, decision support,
niche competitors, documentation & coordination systems, outcome targets, real-time performance measurement, lack of defined PC team based model
Physician work environment redesign StandardizeSimplifyMake clinically relevantEngage patientsFix accountability at the locus of control
![Page 8: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/8.jpg)
Primary Care Focused Case for Quality & Value
Patient Centered Primary Care Collaborative
• 40 year old concept: ACP, AAFP, AAP, AOAPartnership with personal physician, coordinating/integrating/documenting care, promotion of quality & safety, enhanced access, whole person orientation, reduced acute events, reduced utilization, and improved outcomes
• NCQA emerged as one standard setting entity9 Standards3 levels of recognition
• Improved Value reported 2010 and 2012 (Grundy, et al)
Reduced costImproved clinical outcomesImproved patient and provider satisfaction
![Page 9: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/9.jpg)
Era of Health Care ReformTransitioning from Volume to Value
Value = quality/costEnhance Quality by Increasing reliability of
delivery • Focus on execution (processes) of care delivery• Incorporation of High Reliability Principles
Control Cost by Reducing unnecessary utilization• Unnecessary utilization = waste• Failures of delivery, coordination, overtreatment
Demonstration of resultsData transparency, accountability, rapid learning
![Page 10: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/10.jpg)
Focus on Cancer Care
• Microcosm of the US health care systemHigh technologyExpensive new drugsFragmented care
• 1.6 million Americans diagnosed with cancer annually
• Direct costs exceeded $126B in 2010• 0.69% of Commercially insured population• 11-12% of Commercial health care spend• Medicare responsible for > 50% of patients• Fastest growing cost area in medicine
![Page 11: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/11.jpg)
Focus on Cancer Care
• Foundation of medical home and accountable care organizations has been primary care oriented
• Complex care outside the scope of primary care requires delegation to specialists (cancer, nephrology, etc.)
• How does the Primary PCMH or ACOs manage cancer costs if the patient is transferred to oncology?
• Oncology Patient-Centered Medical Home® (OPCMH) model has generated broad interest following recognition by NCQA in 2010
• Oncology PCMH projected to reduce cancer spend
![Page 12: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/12.jpg)
Era of Cancer Care Reform Provider Accountability
“Only those giving the care can improve it”
Failure to control cost (waste, site of care) • Diminishes Value• Results in further funding cuts • Unintended clinical consequences for the most vulnerable• Reduced access, increased co-pays, reduced compliance
Standardization of delivery = waste reduction• Chemotherapy guidelines & pathways• Care delivery beyond chemotherapy selection• Requires practice transformation
![Page 13: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/13.jpg)
Improving the Business Case for Quality
CMOH 2003-2013
Principles of re-designing cancer care delivery:
• Standardize/Streamline (variation in process of care)
• Simplify payment and administrative systems
• Minimize clinically irrelevant physician activity (Make complex decisions & maintain personal relationships)
• PCMH (engage, educate, access, coordination)
• Accountability at physician-patient locus (care team)
• Ongoing data driven process improvement
![Page 14: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/14.jpg)
CMOH: 2009 – 2013
Making a Business Case for Quality• Focus on demand to improve quality and value• Led to development of OPCMH model• NCQA PCMH recognition & QOPI certification• Opportunity to lead positive change
Prepare for future payment models • Episode based, bundles, budgeted payment system
Prepare for future organizational structures• ACO, Hospital System/Payer hybrids, independent
practices, large single TIN networks, Clinically Integrated Networks, etc
![Page 15: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/15.jpg)
Lessons from Medicare Demonstration Projects
CBO Issue Brief January 2012
6 Disease Management & Care Coordination
DemonstrationsGoal: Improve the quality of care for costly, chronic illnessesIn nearly all 34 programs spending was unchanged or increasedAll had 3rd party care management vendors involvedNumber of programs focusing on cancer care – none
4 Value-Based Payment DemonstrationsGoal: Improve quality and efficiency via financial incentives1/4 bundled payment programs resulted in 10% Medicare savingsSuccessful program operated at a lossNumber of programs focusing on cancer care – none
![Page 16: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/16.jpg)
Take Home Message
Changes in payment & delivery systems are necessaryTimely data on use of care (potentially avoidable complications)Focus on transitions of care (Hospital discharge; primary to specialist)Physician-led team-based care (physician, nursing, navigators)Integrate management systems (minimize vendors)Target high-risk patients – predictive modelingRigorous design, concrete answers facilitates rapid learning cycle
Potential for successful re-designing care delivery in oncology
Physician-lead Care Management Team + Patient engagementPromotion of Physician Accountability at the point of deliveryTimely data driving a rapid learning cycle
Lessons from Medicare Demonstration Projects
CBO Issue Brief January 2012
![Page 17: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/17.jpg)
Performance Measurement
![Page 18: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/18.jpg)
The Four Habits of High-Value Health Care Organizations
Everyone believes they are delivering “high quality, highly reliable care”
• Specification and Planning
• Micro-system design
• Measurement and oversight
• Commitment to ongoing process improvement
Richard Bohmer, M.B.,Ch.B. NEJM 12/1/11
![Page 19: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/19.jpg)
Internal Perception
40 50 60 70 80 90 1000
102030405060708090
100
![Page 20: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/20.jpg)
Measured Reality
20 30 40 50 60 70 80 90 1000
102030405060708090
100
![Page 21: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/21.jpg)
“Eminence Based Medicine”
Providing sub-optimal medical care with increasing confidence over an impressive number of years.
~British Medical Journal, Vol. 1 Sept 2001
© Kaufman Strategic Advisors, LLC
![Page 22: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/22.jpg)
Strategic Goal
60 65 70 75 80 85 90 95 1000
102030405060708090
100
![Page 23: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/23.jpg)
How can a physician-led care team reliably deliver cancer care?
Critical Provider Solutions
• Standardized process of care and data collection
• Presentation of consumable data, decision support – with each patient interaction
• Documentation tools to relieve the burden on a physician’s ability to execute care consistently
• Standardized communication
• Real time performance data
![Page 24: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/24.jpg)
IRIS Software SuitePhysician-Centric Software
Enabling Patient-Centered Care• Clinical Decision Support System (CDSS)
– Work-flow integrated with delivery, documentation & MU – Speech-recognition integrated into work-flow– Immediate document completion and auto-dissemination
• Physician performance reports• Physician document and lab management review• Longitudinal performance status & NCI graded symptom
tracking • Triage outcomes & Unscheduled visit tracking• Personalized Patient Assessment and Verification Tool• Enhanced Patient Queuing/tracking program• Individual patient test result and appointment tracking • Screening and Immunization prompts • Portal access for patients and referring physicians• Palliative and End-of-Life Care Management prompts• Enables PCMH-N functionality
![Page 25: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/25.jpg)
Quality, Service & Delivery Parameters
• ASCO - QOPI standards• NCCN Guidelines• American College of Surgeons• NQF, NCPF, NCCS, ONS• CMS - PQRS, e-Rx• NCQA – PPC-PCMHTM
• OPCMH – services• Institute of Medicine
– 1999 Ensuring Quality Cancer Care– 2001 Improving Palliative Care for Cancer– 2006 From Cancer Patient to Cancer Survivor: Lost in Transition– 2009 Assessing & Improving Value in Cancer Care– 2012 Best Care at Lower Cost
![Page 26: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/26.jpg)
Oncology PCMH Model
![Page 27: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/27.jpg)
Oncology Patient-Centered Medical Home® Model
Re-engineered Process of Care & Coordination • Ownership of all aspects of cancer care delivery• Focus on patient needs and evidence-based care• Reduction in unnecessary variation & resource utilization• Enhanced communication with PC PCMH & Specialists• Real-time physician/practice performance measurement• Continuous process improvement
• Encourages Clinical Integration between practices
![Page 28: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/28.jpg)
Oncology Patient-Centered Medical Home® Based on NCQA PPC-PCMHTM
NCQA Standards drive Quality, Service & Utilization
• Enhanced Access & Continuity• Identify and Manage Populations• Plan and Manage Care• Self-care Support & Community Resources• Track and Coordinate Care• Measure and Improve Performance
![Page 29: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/29.jpg)
Process MeasurementRapid Learning Cycle
• Function of mutually reinforcing care-teamInterdependent roles, responsibilities, and hand-offs
• Merging Work-Flow & Clinical Decisions • Guidelines, staging, screening, prevention• Triage & Symptom Management algorithms• Communication/Documentation turn around• Patient Navigating/tracking tests & referrals• Performance Status & Palliative Care tracking• End of life care/promoting shared decisions• Patient & Physician portal utilization• Management of at risk populations
![Page 30: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/30.jpg)
Patient & Payer Centered
Outcome Measures
Patient Experience• AHRQ CAHPS: Consumer Assessment of Healthcare
Providers and Systems
Outcomes• Staging compliance• Chemotherapy guideline adherence• Emergency Room evaluations• Hospital admissions / length of stay• Outpatient visit reduction• End of Life Care parameters• Diagnostics: imaging & laboratory
![Page 31: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/31.jpg)
Results
![Page 32: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/32.jpg)
NCQA PCMH & The Four Habits of High-Value Health Care Organizations
“The ability to disseminate and deliver high value clinical
innovation is based on similar, portable habits of care management … implemented simultaneously” Richard Bohmer, M.B.,Ch.B. NEJM 12/1/11
• Specification and Planning – Merging operational and clinical decisions with documentation
• Micro-system design– Matching subpopulations and pathways, triage algorithms
• Measurement and oversight– Targeting internal operational issues – drive outcomes
• Commitment to ongoing process improvement– Insights for better outcomes fuels modification of Specification and Planning
![Page 33: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/33.jpg)
USON/Milliman: Approximately 1 hospital admission per chemotherapy patient per year (n=14 million commercially insured; 104,473 cancer patients)Source: Milliman analysis of Medstat 2007, Milliman Health Cost Guidelines 2009
![Page 34: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/34.jpg)
USON/Milliman: Approximately 2 emergency room visits per chemotherapy patient per year (n=14 million commercially insured; 104,473 cancer patients)Source: Milliman analysis of Medstat 2007, Milliman Health Cost Guidelines 2009
![Page 35: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/35.jpg)
![Page 36: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/36.jpg)
![Page 37: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/37.jpg)
Guideline & Pathway Adherence
Chemotherapy care plans are NCCN compliantDeviation requires customization (controlled)Physician selects care plan within EMR• Selection shared with billing and nursing staff
NCCN ComplianceAdjuvant and first line metastatic • Adherence > 95% 2007 – 2010 (practice)• Individual physician performance followed
Pathway ComplianceSmall number of patients > 80%
![Page 38: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/38.jpg)
OPCMH End-of-Life Care Collaborative Dartmouth OPCMHTM QOPI Measure
Death in hospital % X X PH numerator; denominator ? Practice*
Hospital admissions, last 30 days, % X X PH numerator; denominator ?
Practice*
ICU admissions, last 30 days, % X X PH numerator; denominator ? Practice*
ICU Days, last 30 days X X PH numerator; denominator ? Practice*
ChemoRx, last 30 days X X X PH numerator; denominator ? Practice*
Hospice, last 30 days, % X X PH numerator; denominator ? Practice*
Hospice days, last 30 days X X PH numerator; denominator ? Practice*
Hospice within 7 days of death, % X X X PH numerator; denominator ? Practice*
Hospice enrollment, % X X PH numerator; denominator ? Practice*
ACP discussion with metastatic disease X X PH numerator and
denominator
Advanced care plan documented, % X Practice
ECOG performance status documented at each visit X Practice
![Page 39: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/39.jpg)
OPCMH End of Life Care• Performance Status Driven
Influences ongoing treatment decisionsStandardized assessment & longitudinal tracking of PS Impact of disease & therapy on abilities, QOLAuditing for PS decline (ECOG 3)
Ongoing Discussion of Goals of TherapyDocumentation at onset of stage IV diseaseDocumentation of ongoing discussion with decline in PS, change in therapyGoal: Promote shared decision-making
![Page 40: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/40.jpg)
End of Life Care Data
• Hospice Average Length of Stay:2009: 26 days 2010: 32 days2011: 35 days
• Place at time of death: 70% home 2010
74% home 2011
• ER visits & hospital admissions last 30 days of life:– 2010: 39.3% total practice Admissions– 2011: 36.4% total practice Admissions – 2010: 23.8% total practice ER visits– 2011: 20.1% total practice ER visits
34% increase
![Page 41: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/41.jpg)
Oncology PCMH Impact on Cost of Cancer Care
Projected % Reduction in Cancer Care Cost
1-3 Chemotherapy pathways program4-6.3 Inpatient hospitalizations (5-25% reduction).6-1.1 ER evaluations (20-40%).1-.4 Diagnostics.9-1.9 End-of-life care coordination
Total 6.6 – 12.7 % reductionAnnual cancer “spend” $125B = $8-16B savings
Adapted from international consultants evaluation of OPCMHTM application to cancer care
![Page 42: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/42.jpg)
Replication
![Page 43: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/43.jpg)
Replication of the ModelFour Key Steps
Specialty societies define quality parameters• ASCO, ACOS, NCCN, COA, NQF, NCPF
NCQA Specialty Practice Recognition Program• Application of PCMH principles to specialties• Specialty Practice standards March 2013
Payer engagement and support• Regional and national payers
Phases of construction of PC-SP• Payer Incentives & Practice Deliverables defined
![Page 44: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/44.jpg)
NCQA PC-SPR Transformation vs other Quality Improvement models
NCQA Standards are based on:Service, quality, utilization, meaningful use
• Standardized processes across practice• Re-defined roles - supporting a physician-
led team• Promotion of physician efficiency &
accountability• Applicable to Oncology, Nephrology,
Cardiology, Rheumatology
![Page 45: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/45.jpg)
Level of Oncology Accountability Models for Payment of cancer care
FFS Pathways OPCMH Bundled or Episode Payment
![Page 46: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/46.jpg)
Oncology Patient-Centered Medical Home® Value Proposition
• OPCMH – clinical & business methodologies– Data driven practice/patient care efficiencies– Community and hospital-based practices
• OPCMH - organizational construct– Oncology “plug-in” to PCMH as a PCMH-N– Establishes care management accountability– Communication that bridges specialists and PCMH
• OPCMH – as PCMH bridge– Aligns oncologists for ACO, Clinical Integration, etc– Platform for pricing bundles, episodes, etc or
episode of care payment
![Page 47: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/47.jpg)
Stakeholder Perspective
![Page 48: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/48.jpg)
Patients & Payers Want Reliable Patient-Centered Services
• Personal relationship with a physician– Explanation, Prediction, Plan of intervention
• “On demand” access to care & information• Total coordination of all aspects of care• Communication among all providers of care • Best possible outcomes– Improvement & preservation of quality of life– Fewer complications, ER, hospital admissions, visits• Fewer co-pay related events
– Rational care at the end of life
![Page 49: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/49.jpg)
Summary
• Foundation of PCMH and ACOs are primary care oriented
• Costly care exists outside the scope of primary care• Primary care delegates management of complex care
(cancer, nephrology, etc) to specialists• The specialty community has the capacity to
dramatically improve care and reduce costs• This requires practices to transform the way they
deliver care, which requires stakeholder collaboration • Payers need to promote physician driven efforts to
enhance value & continuously improve care delivery
![Page 50: Oncology Patient-Centered Medical Home ® Business Case for Quality Value Based Hematology and Oncology Care John D. Sprandio, M.D., FACP Consultants in](https://reader038.vdocuments.us/reader038/viewer/2022110116/5516884a5503469d698b60c7/html5/thumbnails/50.jpg)
Questions
For more information about Oncology Patient Centered Medical Home:
John Sprandio [email protected]
Susan Tofani [email protected] www.OPCMH.com